International Journal of Clinical Medicine

Vol.2 No.1(2011), Paper ID 3928, 5 pages

DOI:10.4236/ijcm.2011.21005

 

Historical Cohort Study of the Efficacy and Safety of Piperacillin/Tazobactam Versus Fourth-Generation Cephalosporins for Empirical Treatment of Febrile Neutropenia in Patients with Hematological Malignancies

 

Takashi Saito, Tatsuo Ichinohe, Junya Kanda, Miki Nagao, Shunji Takakura, Yutaka Ito, Yoshitsugu Iinuma, Kouhei Yamashita, Tadakazu Kondo, Takayuki Ishikawa, Takashi Uchiyama, Satoshi Ichiyama

 

 

Copyright © 2011 Takashi Saito, Tatsuo Ichinohe, Junya Kanda, Miki Nagao, Shunji Takakura, Yutaka Ito, Yoshitsugu Iinuma, Kouhei Yamashita, Tadakazu Kondo, Takayuki Ishikawa, Takashi Uchiyama, Satoshi Ichiyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


T. Saito, T. Ichinohe, J. Kanda, M. Nagao, S. Takakura, Y. Ito, Y. Iinuma, K. Yamashita, T. Kondo, T. Ishikawa, T. Uchiyama and S. Ichiyama, "Historical Cohort Study of the Efficacy and Safety of Piperacillin/Tazobactam Versus Fourth-Generation Cephalosporins for Empirical Treatment of Febrile Neutropenia in Patients with Hematological Malignancies," International Journal of Clinical Medicine, Vol. 2 No. 1, 2011, pp. 18-22. doi: 10.4236/ijcm.2011.21005.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.